These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 15811961

  • 1. Vav proteins are required for B-lymphocyte responses to LPS.
    Hebeis B, Vigorito E, Kovesdi D, Turner M.
    Blood; 2005 Jul 15; 106(2):635-40. PubMed ID: 15811961
    [Abstract] [Full Text] [Related]

  • 2. CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes.
    Yazawa N, Fujimoto M, Sato S, Miyake K, Asano N, Nagai Y, Takeuchi O, Takeda K, Okochi H, Akira S, Tedder TF, Tamaki K.
    Blood; 2003 Aug 15; 102(4):1374-80. PubMed ID: 12714520
    [Abstract] [Full Text] [Related]

  • 3. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.
    Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, Fredericks J, Nishi S, Mildiner S, Moores SL, Brugge J, Rosen FS, Swat W.
    J Exp Med; 2003 Nov 17; 198(10):1595-608. PubMed ID: 14623913
    [Abstract] [Full Text] [Related]

  • 4. Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation.
    Doody GM, Bell SE, Vigorito E, Clayton E, McAdam S, Tooze R, Fernandez C, Lee IJ, Turner M.
    Nat Immunol; 2001 Jun 17; 2(6):542-7. PubMed ID: 11376342
    [Abstract] [Full Text] [Related]

  • 5. Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte.
    Tartare-Deckert S, Monthouel MN, Charvet C, Foucault I, Van Obberghen E, Bernard A, Altman A, Deckert M.
    J Biol Chem; 2001 Jun 15; 276(24):20849-57. PubMed ID: 11262396
    [Abstract] [Full Text] [Related]

  • 6. Vav1, but not Vav2, contributes to platelet aggregation by CRP and thrombin, but neither is required for regulation of phospholipase C.
    Pearce AC, Wilde JI, Doody GM, Best D, Inoue O, Vigorito E, Tybulewicz VL, Turner M, Watson SP.
    Blood; 2002 Nov 15; 100(10):3561-9. PubMed ID: 12411320
    [Abstract] [Full Text] [Related]

  • 7. Vav family proteins couple to diverse cell surface receptors.
    Moores SL, Selfors LM, Fredericks J, Breit T, Fujikawa K, Alt FW, Brugge JS, Swat W.
    Mol Cell Biol; 2000 Sep 15; 20(17):6364-73. PubMed ID: 10938113
    [Abstract] [Full Text] [Related]

  • 8. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide.
    Nagai Y, Shimazu R, Ogata H, Akashi S, Sudo K, Yamasaki H, Hayashi S, Iwakura Y, Kimoto M, Miyake K.
    Blood; 2002 Mar 01; 99(5):1699-705. PubMed ID: 11861286
    [Abstract] [Full Text] [Related]

  • 9. Vav-family proteins in T-cell signalling.
    Tybulewicz VL.
    Curr Opin Immunol; 2005 Jun 01; 17(3):267-74. PubMed ID: 15886116
    [Abstract] [Full Text] [Related]

  • 10. The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens.
    Bachmann MF, Nitschke L, Krawczyk C, Tedford K, Ohashi PS, Fischer KD, Penninger JM.
    J Immunol; 1999 Jul 01; 163(1):137-42. PubMed ID: 10384109
    [Abstract] [Full Text] [Related]

  • 11. Vav and the B cell signalosome.
    DeFranco AL.
    Nat Immunol; 2001 Jun 01; 2(6):482-4. PubMed ID: 11376331
    [No Abstract] [Full Text] [Related]

  • 12. Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor.
    Glassford J, Holman M, Banerji L, Clayton E, Klaus GG, Turner M, Lam EW.
    J Biol Chem; 2001 Nov 02; 276(44):41040-8. PubMed ID: 11546804
    [Abstract] [Full Text] [Related]

  • 13. Vav1 increases Bcl-2 expression by selective activation of Rac2-Akt in leukemia T cells.
    Wan YJ, Yang Y, Leng QL, Lan B, Jia HY, Liu YH, Zhang CZ, Cao Y.
    Cell Signal; 2014 Oct 02; 26(10):2202-9. PubMed ID: 24880064
    [Abstract] [Full Text] [Related]

  • 14. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
    Nagai Y, Yanagibashi T, Watanabe Y, Ikutani M, Kariyone A, Ohta S, Hirai Y, Kimoto M, Miyake K, Takatsu K.
    Int Immunol; 2012 Jun 02; 24(6):389-400. PubMed ID: 22354914
    [Abstract] [Full Text] [Related]

  • 15. Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen.
    Pearce AC, Senis YA, Billadeau DD, Turner M, Watson SP, Vigorito E.
    J Biol Chem; 2004 Dec 24; 279(52):53955-62. PubMed ID: 15456756
    [Abstract] [Full Text] [Related]

  • 16. Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling.
    Tedford K, Nitschke L, Girkontaite I, Charlesworth A, Chan G, Sakk V, Barbacid M, Fischer KD.
    Nat Immunol; 2001 Jun 24; 2(6):548-55. PubMed ID: 11376343
    [Abstract] [Full Text] [Related]

  • 17. Role of vav1 in the lipopolysaccharide-mediated upregulation of inducible nitric oxide synthase production and nuclear factor for interleukin-6 expression activity in murine macrophages.
    Godambe SA, Knapp KM, Meals EA, English BK.
    Clin Diagn Lab Immunol; 2004 May 24; 11(3):525-31. PubMed ID: 15138177
    [Abstract] [Full Text] [Related]

  • 18. Vav GEFs are required for beta2 integrin-dependent functions of neutrophils.
    Gakidis MA, Cullere X, Olson T, Wilsbacher JL, Zhang B, Moores SL, Ley K, Swat W, Mayadas T, Brugge JS.
    J Cell Biol; 2004 Jul 19; 166(2):273-82. PubMed ID: 15249579
    [Abstract] [Full Text] [Related]

  • 19. Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help.
    Gulbranson-Judge A, Tybulewicz VL, Walters AE, Toellner KM, MacLennan IC, Turner M.
    Eur J Immunol; 1999 Feb 19; 29(2):477-87. PubMed ID: 10064063
    [Abstract] [Full Text] [Related]

  • 20. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity.
    Cella M, Fujikawa K, Tassi I, Kim S, Latinis K, Nishi S, Yokoyama W, Colonna M, Swat W.
    J Exp Med; 2004 Sep 20; 200(6):817-23. PubMed ID: 15365099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.